✦ LIBER ✦

Clinical and cytogenetic findings in the terminal phase of chronic myelogenous leukaemia

✍ Scribed by E. Castro-Sierra; L. Z. Gorman; H. Merker; P. Obrecht; U. Wolf

Publisher: Springer
Year: 1967
Tongue: English
Weight: 634 KB
Volume: 4
Category: Article
ISSN: 0340-6717
DOI: 10.1007/bf00279181

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Oral idarubicin in the treatment of acut

Oral idarubicin in the treatment of acute myelogenous leukaemia and the blast phase of chronic myeloid leukaemia

✍ S. T. A. Malik; J. Tucker; A. Z. S. Rohatiner; W. Brace; T. A. Lister 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 307 KB

Fourteen patients with poor-risk acute myelogenous leukaemia (AML) and five patients with accelerated phase/blast crisis chronic myeloid leukaemia (CML) were treated with 3 days of oral idarubicin (25 mg/m2/ day). No complete remissions or return to chronic phase CML were observed. A fall in the per

Therapy adapted to molecular response in

Therapy adapted to molecular response in patients with chronic myelogenous leukaemia in first chronic phase: results of the Duesseldorf study

✍ Frank Neumann; Judith Markett; Roland Fenk; Monika Pooten; Anne Koch; Daniela Br 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB

## Abstract This study evaluates response‐adapted treatment of chronic myelogenous leukaemia (CML) in chronic phase using molecular response criteria. __bcr‐abl__/G6PDH ratios were assessed by Light‐Cycler quantitative real‐time polymerase chain reaction (PCR( in 277 peripheral blood samples from 3

Prognostic value of chromosomal findings

Prognostic value of chromosomal findings in the blast phase of Ph1-positive chronic myeloid leukaemia (CML)

✍ ÉVa Oláh; Kálmán Rák 📂 Article 📅 1981 🏛 John Wiley and Sons 🌐 French ⚖ 584 KB

## Abstract Twenty‐three patients in various cytological subgroups of blast phase of Ph^1^‐positive chronic myeloid leukaemia were investigated cytogenetically. The correlation between prognosis and the cytological and cytogenetic features of blast cells was studied. The best prognosis was found in

Regression with bounded outcome score: e

Regression with bounded outcome score: evaluation of power by bootstrap and simulation in a chronic myelogenous leukaemia clinical trial

✍ A. Tsodikov; D. Hasenclever; M. Loeffler 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 149 KB 👁 2 views

Evaluation of the treatment effect on cytogenetic ordered categorical response is considered in patients treated for chronic myelogenous leukaemia (CML) in a clinical trial initiated by the East German Group for Hematology and Oncology. A simulation model for the cytogenetic response (per cent of Ph

Cytogenetic and molecular responses in c

Cytogenetic and molecular responses in chronic phase chronic myeloid leukaemia patients receiving low dose of imatinib for intolerance to standard dose

✍ Massimo Breccia; Laura Cannella; Caterina Stefanizzi; Roberto Latagliata; Mauro 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

## Abstract Imatinib mesylate is the gold standard treatment of chronic myeloid leukaemia (CML) and 400 mg/day is considered the standard dose. Although it is generally well tolerated, some patients require temporary drug discontinuation and permanent dose reduction because of haematological or non

Cytogenetic, fluorescence in situ hybrid

Cytogenetic, fluorescence in situ hybridisation, and clinical evaluation of translocations with concomitant deletion at 13q14 in chronic lymphocytic leukaemia

✍ Anne C. Gardiner; Martin M. Corcoran; David G. Oscier 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 209 KB 👁 1 views

Deletions and translocations of 13q14 are the most frequent structural chromosome abnormalities found in chronic lymphocytic leukaemia (CLL). We have identified 13q14 translocations in the blood of 30 of 450 (6.6%) CLL patients by conventional cytogenetics, using tetradecanoyl phorbol 12-myristate 1